País: Irlanda
Idioma: anglès
Font: HPRA (Health Products Regulatory Authority)
PROCHLORPERAZINE MESILATE
Mercury Pharmaceuticals (Ireland) Ltd
PROCHLORPERAZINE MESILATE
25 Mg/Ml
Solution for Injection
Product subject to prescription which may not be renewed (A)
Withdrawn
0000-00-00
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0073/129/002 Case No: 2076970 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to ANTIGEN PHARMACEUTICALS LTD CHANDLER HOUSE, CASTLE STREET, ROSCREA, CO TIPPERARY, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product PROCHLORPERAZINE INJECTION BP 25MG IN 2ML The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 07/04/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 07/04/2010_ _CRN 2076970_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Prochlorperazine Injection BP 25mg in 2ml 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2ml of solution contains 25mg (1.25% w/v) of Prochlorperazine Mesilate BP. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Colourless or almost colourless sterile solution for injection. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the symptomatic treatment of acute vertigo such as is associated with Meniere's syndrome, and for nausea and vomiting from whatever cause including that associated with migraine. It is also used in the management of schizophrenia, acute mania, phobi Llegiu el document complet